What Is the Role of Ovarian Ablation in the Management of Primary and Metastatic Breast Cancer Today?

What Is the Role of Ovarian Ablation in the Management of Primary and Metastatic Breast Cancer Today? Tatiana M. Prowell, Nancy E. Davidson Oncologist 2004; 9: 507-517 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the pros and cons of various methods of ovarian ablation, including oophorectomy, radiation therapy, and LHRH analogs. Recall the frequency of chemotherapy-related amenorrhea with commonly used regimens in adjuvant breast cancer treatment. Discuss the evidence supporting the use of ovarian ablation in premenopausal women with early-stage breast cancer. Discuss the evidence supporting the use of ovarian ablation in premenopausal women with HR+ metastatic breast cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Oct. 11, 2004 Most Recent Review: Oct. 11, 2004* Most Recent Update: Oct. 11, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.